Identification of Six Potentially Long Noncoding RNAs As Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2018 Nov 9

PMID 30406146

Citations 19

Authors

Kang Yang

Xiao-Fan Lu

Peng-Cheng Luo

Jie Zhang

Affiliations

Soon will be listed here.

Abstract

. Clear cell renal cell carcinoma (ccRCC), the most common subtype of renal cell carcinoma (RCC), usually is representative of metastatic heterogeneous neoplasm that links with poor prognosis, but the pathogenesis of ccRCC remains unclear. Currently, numerous evidences prove that long noncoding RNAs (lncRNAs) are considered as competing endogenous RNA (ceRNA) to participate in cellular processes of tumors. Therefore, to investigate the underlying mechanisms of ccRCC, the expression profiles of lncRNAs, miRNAs, and mRNAs were downloaded from the Cancer Genome Atlas (TCGA) database. A total of 1526 differentially expressed lncRNAs (DElncRNAs), 54 DEmiRNAs, and 2352 DEmRNAs were identified. To determine the connection of them, all DElncRNAs were input to the miRcode database. The results indicated that 85 DElncRNAs could connect with 9 DEmiRNAs in relation to our study. Then, databases of TargetScan and miRDB were used to search for targeted genes with reference to DEmiRNAs. The results showed that 203 out of 2352 targeted genes were identified in our TCGA set. Subsequently, ceRNA network was constructed according to Cytoscape and the targeted genes were functionally analyzed to elucidate the mechanisms of DEmRNAs. The results of survival analysis and regression analysis indicated that 6 DElncRNAs named COL18A1-AS1, WT1-AS, LINC00443, TCL6, AL356356.1, and SLC25A5-AS1 were significantly correlative with the clinical traits of ccRCC patients and could be served as predictors for ccRCC. Finally, these findings were validated by quantitative RT-PCR (qRT-PCR). Based on these discoveries, we believe that this identified ceRNA network will provide a novel perspective to elucidate ccRCC pathogenesis.

Citing Articles

Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma.

Bohosova J, Kozelkova K, Al Tukmachi D, Trachtova K, Naar O, Ruckova M J Cancer Res Clin Oncol. 2023; 149(10):7587-7600.

PMID: 36988708 PMC: 10374689. DOI: 10.1007/s00432-023-04700-7.

The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.

Rysz J, Konecki T, Franczyk B, Lawinski J, Gluba-Brzozka A Int J Mol Sci. 2023; 24(1).

PMID: 36614082 PMC: 9820502. DOI: 10.3390/ijms24010643.

Transcriptional and genetic alterations of cuproptosis-related genes correlated to malignancy and immune-infiltrate of esophageal carcinoma.

Jiang R, Huan Y, Li Y, Gao X, Sun Q, Zhang F Cell Death Discov. 2022; 8(1):370.

PMID: 35995782 PMC: 9395517. DOI: 10.1038/s41420-022-01164-5.

Restoring the epigenetically silenced lncRNA COL18A1-AS1 represses ccRCC progression by lipid browning via miR-1286/KLF12 axis.

Liu Y, Wang J, Shou Y, Xu W, Huang Z, Xu J Cell Death Dis. 2022; 13(7):578.

PMID: 35787628 PMC: 9253045. DOI: 10.1038/s41419-022-04996-2.

Four Prognosis-Associated lncRNAs Serve as Biomarkers in Ovarian Cancer.

Zheng J, Guo J, Zhang H, Cao B, Xu G, Zhang Z Front Genet. 2021; 12:672674.

PMID: 34367239 PMC: 8336869. DOI: 10.3389/fgene.2021.672674.

References

Butz H, Szabo P, Nofech-Mozes R, Rotondo F, Kovacs K, Mirham L . Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma. Clin Chem. 2014; 60(10):1314-26. DOI: 10.1373/clinchem.2014.225854. View

Meng J, Li P, Zhang Q, Yang Z, Fu S . A four-long non-coding RNA signature in predicting breast cancer survival. J Exp Clin Cancer Res. 2014; 33:84. PMC: 4198622. DOI: 10.1186/s13046-014-0084-7. View

Lv M, Zhong Z, Huang M, Tian Q, Jiang R, Chen J . lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Biochim Biophys Acta Mol Cell Res. 2017; 1864(10):1887-1899. DOI: 10.1016/j.bbamcr.2017.08.001. View

Yuan P, Cao W, Zang Q, Li G, Guo X, Fan J . The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy. Biochem Biophys Res Commun. 2016; 478(3):1067-73. DOI: 10.1016/j.bbrc.2016.08.065. View

Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F . International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 2014; 67(3):519-30. DOI: 10.1016/j.eururo.2014.10.002. View

Capitanio U, Montorsi F . Renal cancer. Lancet. 2015; 387(10021):894-906. DOI: 10.1016/S0140-6736(15)00046-X. View

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

Lv L, Chen G, Zhou J, Li J, Gong J . WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1. J Exp Clin Cancer Res. 2015; 34:119. PMC: 4604772. DOI: 10.1186/s13046-015-0233-7. View

10.

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

11.

Tomczak K, Czerwinska P, Wiznerowicz M . The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015; 19(1A):A68-77. PMC: 4322527. DOI: 10.5114/wo.2014.47136. View

12.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

13.

Du T, Zhang B, Zhang S, Jiang X, Zheng P, Li J . Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. Biochim Biophys Acta. 2015; 1862(1):12-9. DOI: 10.1016/j.bbadis.2015.10.001. View

14.

Ommen H, Nyvold C, Braendstrup K, Andersen B, Ommen I, Hasle H . Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals. Br J Haematol. 2008; 141(6):782-91. DOI: 10.1111/j.1365-2141.2008.07132.x. View

15.

Li F, Li Q, Wu X . Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer. PLoS One. 2018; 13(2):e0192494. PMC: 5805314. DOI: 10.1371/journal.pone.0192494. View

16.

Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y . miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci. 2011; 124(Pt 17):2997-3005. DOI: 10.1242/jcs.085050. View

17.

Jeggari A, Marks D, Larsson E . miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 2012; 28(15):2062-3. PMC: 3400968. DOI: 10.1093/bioinformatics/bts344. View

18.

Zou J, Kuang W, Hu J, Rao H . miR-216b promotes cell growth and enhances chemosensitivity of colorectal cancer by suppressing PDZ-binding kinase. Biochem Biophys Res Commun. 2017; 488(2):247-252. DOI: 10.1016/j.bbrc.2017.03.162. View

19.

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

20.

Sato Y, Yoshizato T, Shiraishi Y, Maekawa S, Okuno Y, Kamura T . Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet. 2013; 45(8):860-7. DOI: 10.1038/ng.2699. View